Toronto, Canada

Evan Lindsay Ronan

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Evan Lindsay Ronan. Retrieved from https://idiyas.com/inventor/evan-lindsay-ronan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: The Innovations of Evan Lindsay Ronan

Introduction

Evan Lindsay Ronan is an innovative inventor based in Toronto, Canada. He has made significant contributions to the field of antimicrobial technologies. His work focuses on the preparation of sulfonamide-containing antimicrobials and substrate treating compositions.

Latest Patents

Evan holds a patent titled "Preparation Of Sulfonamide-Containing Antimicrobials And Substrate Treating Compositions Of Sulfonamide-Containing Antimicrobials." This patent involves a quaternary ammonium sulfonamide compound with a complex formula that includes various alkyl groups and halogens. The invention aims to provide effective antimicrobial surface coating compositions.

Career Highlights

Evan is currently employed at Nano Safe Coatings Incorporated, where he continues to develop innovative solutions in antimicrobial coatings. His expertise in this area has positioned him as a valuable asset to his company.

Collaborations

Evan has collaborated with notable colleagues, including Daniel A. Foucher and Gideon Wolfaardt. Their combined efforts contribute to advancing the field of antimicrobial technologies.

Conclusion

Evan Lindsay Ronan's work exemplifies the spirit of innovation in the field of antimicrobial solutions. His contributions are paving the way for advancements in this critical area of research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…